annexonbio.comHealthcareFounded: 2011Funding to Date: $154MM
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain.
View Enterprise Value for Annexon Biosciences.